Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blood cell counts may reveal hidden cancer risk in triple negative breast cancer

NCT ID NCT04068623

Ongoing Knowledge-focused Sponsor: Centre Jean Perrin Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether certain blood cell counts and tumor-infiltrating lymphocytes can help predict if triple negative breast cancer will come back. Researchers will collect blood samples from 90 women after radiation and at the time of any first recurrence. The goal is to find a simple, inexpensive way to identify patients at higher risk of metastatic recurrence.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to a simple blood test to help predict which patients are at higher risk of their breast cancer returning.
What could go wrong
This is an observational study, not a treatment trial. It is small (90 people) and only looks at correlations, so it may not lead to a reliable test.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TRIPLE NEGATIVE BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

triple-negative breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TRIPLE NEGATIVE BREAST CANCER

Contacts and locations

Locations

  • Centre Jean PERRIN

    Clermont-Ferrand, Please Select, 63000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.